Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LENALIDOMIDA GLENMARK 10 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LENALIDOMIDA GLENMARK 10 MG CAPSULAS DURAS EFG

Approved

STANDARD

LENALIDOMIDA GLENMARK 10 MG CAPSULAS DURAS EFG

Glenmark Arzneimittel Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 9, 2021
Approval ID: 0ff42b3bb236fe1f
Company: Glenmark Arzneimittel Gmbh
Type: Standard

Approval Details

Approval Id: 0ff42b3bb236fe1f
Drug Cima Aemps Name: LENALIDOMIDA GLENMARK 10 MG CAPSULAS DURAS EFG
Register Number: 85672
Holder Company Name: Glenmark Arzneimittel Gmbh
Marketing Company Name: Viso Farmaceutica S.L.U.
Holder Company Detail Path: /organization/glenmark-arzneimittel-gmbh
Authorization Date: 2021-02-09
Dosage Form: CÁPSULA DURA
Dose: 10 mg
Route Of Administration: VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Glenmark Arzneimittel Gmbh
Company Detail Path: /organization/glenmark-arzneimittel-gmbh

Company Information

Pharmaceutical Company Name: Glenmark Arzneimittel GmbH
Country Name: Germany
Website: http://www.glenmark.de

Active Ingredients

LENALIDOMIDA

10 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 9, 2021

Approval ID

0ff42b3bb236fe1f

Type

Standard

Back to CIMA-AEMPS Approvals